Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 259

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

L‐arginine‐induced vasodilation in healthy humans:pharmacokinetic–pharmacodynamic relationship

Open access
Bode‐Böger, Stefanie M., Böger, Rainer H., Galland, Andrea, Tsikas, Dimitrios, Frölich, Jürgen C. · 1998 · British Journal of Clinical Pharmacology

Abstract

Aims Administration of l‐arginine by intravenous infusion or via oral absorption has been shown to induce peripheral vasodilation in humans, and to improve endothelium‐dependent vasodilation. We investigated the pharmacokinetics and pharmacokinetic‐pharmacodynamic relationship of l‐arginine after a single intravenous infusion of 30 g or 6 g, or after a single oral application of 6 g, as compared with the respective placebo, in eight healthy male human subjects. Methods l‐arginine levels were determined by h.p.l.c. The vasodilator effects of l‐arginine were assessed non‐invasively by blood pressure monitoring and impedance cardiography. Urinary nitrate and cyclic GMP excretion rates were measured as non‐invasive indicators of endogenous NO production. Results Plasma l‐arginine levels increased to (mean±s.e.mean) 6223±407 (range, 5100–7680) and 822±59 (527–955) μmol l−1 after intravenous infusion of 30 g and 6 g l‐arginine, respectively, and to 310±152 (118–1219) μmol l−1 after oral ingestion of 6 g l‐arginine. Oral bioavailability of l‐arginine was 68±9 (51–87)%. Clearance was 544±24 (440–620), 894±164 (470–1190), and 1018±230 (710–2130) ml min−1, and elimination half‐life was calculated as 41.6±2.3 (34–55), 59.6±9.1 (24–98), and 79.5±9.3 (50–121) min, respectively, for 30 g i.v., 6 g i.v., and 6 g p.o. of l‐arginine. Blood pressure and total peripheral resistance were significantly decreased after intravenous infusion of 30 g l‐arginine by 4.4±1.4% and 10.4±3.6%, respectively, but were not significantly changed after oral or intravenous administration of 6 g l‐arginine. l‐arginine (30 g) also significantly increased urinary nitrate and cyclic GMP excretion rates by 97±28 and 66±20%, respectively. After infusion of 6 g l‐arginine, urinary nitrate excretion also significantly increased, (nitrate by 47±12% [P<0.05], cyclic GMP by 67±47% [P=ns]), although to a lesser and more variable extent than after 30 g of l‐arginine. The onset and the duration of the vasodilator effect of l‐arginine and its effects on endogenous NO production closely corresponded to the plasma concentration half‐life of l‐arginine, as indicated by an equilibration half‐life of 6±2 (3.7–8.4) min between plasma concentration and effect in pharmacokinetic‐pharmacodynamic analysis, and the lack of hysteresis in the plasma concentration‐versus‐effect plot. Conclusions The vascular effects of l‐arginine are closely correlated with its plasma concentrations. These data may provide a basis for the utilization of l‐arginine in cardiovascular diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2125.1998.00803.x

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 259

Metadata

Authors
Bode‐Böger, S. M., Böger, R. H., Galland, A., Tsikas, D., & Frölich, J. C.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
1998-11
Volume
46
Issue
5
Pages
489-497
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W2162066244
Cited by
259
References
50
FWCI
3.01
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: L‐arginine‐induced vasodilation in healthy humans:pharmacokinetic–pharmacodynamic relationship. https://app.cochat.ai/papers/10.1046/j.1365-2125.1998.00803.x
The paper
Bode‐Böger, S. M., Böger, R. H., Galland, A., Tsikas, D., & Frölich, J. C. (1998). L‐arginine‐induced vasodilation in healthy humans:pharmacokinetic–pharmacodynamic relationship. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.1998.00803.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.